Stay updated with breaking news from Nelluri Geetha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Innovent Biologics has revealed encouraging phase 3 (DREAMS-2) findings for mazdutide, showcasing its superiority over dulaglutide in managing glycemic levels among patients with type 2 diabetes (T2D) in China.
24 May, 2024 Innovent Biologics mazdutide can pave way for transformative T2D treatment, says GlobalData Share Print page ...
A recent study finds RNA deals are “dominated” by oligonucleotides and mRNA vaccines in APAC
In a significant development for the multiple myeloma community, Menarini Stemline UK today welcomed the final draft guidance from the National Institute for Health and Care Excellence (NICE).